Search

Your search keyword '"Na I"' showing total 189 results

Search Constraints

Start Over You searched for: Author "Na I" Remove constraint Author: "Na I"
189 results on '"Na I"'

Search Results

1. The Belle II Detector Upgrades Framework Conceptual Design Report

2. Ibrutinib + bortezomib + R‐CHOP for higher‐risk DLBCL: Feasibility, efficacy and molecular predictors

5. 180P FIRE-6: Longitudinal immune profiling identified disturbed NK cell functionality in RAS/BRAF wild-type metastatic colorectal cancer patients and during combined treatment with FOLFIRI, cetuximab followed by avelumab maintenance

6. 581P mRNA profiling as a biomarker of prognosis and response to first-line treatment in metastatic colorectal cancer: Discovery and validation of a gene expression signature in three randomized trials

10. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

12. Taxonomy of the Apicomplexan Symbionts of Coral, including Corallicolida ord. nov., Reassignment of the Genus Gemmocystis, and Description of New Species Corallicola aquarius gen. nov. sp. nov. and Anthozoaphila gnarlus gen. nov. sp. nov

16. Lumen-apposing metal stents: How far are we from standardization? An Italian survey

23. NOD2 deficiency in experimental GvHD: O288

26. Simulation Of Optimal Path Planning Using Modified Minimum Spanning Tree For Autonomous Agricultural Mobile Robots

27. Detection Of Rice Grain Using Low Altitude Uav Images At Growing Stage

30. High response rates in patients treated with ruxolitinib for corticosteroid-refractory Graft-versus-host disease: analysis including 13 Transplant Centers

31. Ruxolitinib for corticosteroid-refractory graft-versus-host disease: analysis of 95 patients treated at multiple medical centers

32. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

36. Rabbit antithymocyte globulin (Thymoglobulin(R)) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients

37. Trail Over-Expression on Donor T Cells Enhances GVT and Suppresses GVHD by Inhibiting Alloreactive T Cells and Impairing Host APC Functions

39. Abrogation of Donor T Cell IL-21 Signaling Leads to Tissue-Specific Modulation of Immunity and Separation of GVHD From GVL

40. Genetically Engineered Donor T Cells for BMT Immunotherapy: Expression of Trail and PLZF Selectively Enhances GVT and Abrogates GVHD

41. Nrf2 Regulates Alloreactive T Cell Function During GVHD

43. Over-Expression Of Trail On Donor T Cells Simultaneously Ameliorates GVHD And Enhances GVT

44. P-Selectin Regulates Leukocyte Trafficking And Experimental Graft-Versus-Host-Disease After Allogeneic Bone Marrow Transplantation

45. TRAIL/DR5 Interactions Are Important For Mediating Thymic Damage After Allogeneic Bone Marrow Transplantation

46. The T Cell Cytolytic Molecules Fas Ligand And Trail, The Trafficking Molecules CCR9, β7 Integrin And PSGL1, And The Immune Modulating Molecules OX40 And Ceacam1 Are Required For Thymic Graft-Versus-Host Disease

47. Depletion of Vascular Endothelial Progenitor Cells Simultaneously Ameliorates GVHD and Inhibits Tumor Growth

48. Ceacam1 Regulates Experimental Graft-Versus-Host-Disease

50. 27: IL-17 is Required for CD4-Mediated GVHD

Catalog

Books, media, physical & digital resources